NCT01606410

Brief Summary

Rationale: Ischaemic preconditioning (IP) refers to the reduction of ischemia-reperfusion injury induced by a brief preceding period of ischemia. Also the arterial endothelium can be protected by IP. Several studies performed in animals and humans have demonstrated that the protective effects of IP are attenuated with aging. However, no previous study directly examined the underlying mechanisms of this observation. Possibly, the reduced protective effect of IP with aging relates to a direct effect on the endothelium, consequently leading to an attenuated ability of IP to prevent endothelial dysfunction after ischaemia reperfusion injury. Several previous studies failed to demonstrate the ability of pharmacological stimuli to mimic the beneficial effects of IP in aged vessels. Restoration of the age-related reduction in effectiveness of IP may be possible through exercise training. In aged animals, physical training restores the efficacy of ischemic preconditioning. Indirect evidence indicates that physical activity, independent of other cardiovascular risk factors, protects against a occurrence as well as the severity of a myocardial infarction in humans. Although this suggests that physical activity may beneficially influence the age-related reduction in IP, no previous study provided direct evidence for this hypothesis. Objective: To examine the impact of age and physical fitness on the ability of ischaemic preconditioning to protect endothelial damage in response to ischaemia reperfusion injury in healthy humans. A secondary objective is to explore the role of Toll-like receptor (TLR) signalling in the induction of IP in young and old subjects.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2011

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2011

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

May 23, 2012

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 25, 2012

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2013

Completed
Last Updated

November 20, 2013

Status Verified

November 1, 2013

Enrollment Period

2.6 years

First QC Date

May 23, 2012

Last Update Submit

November 19, 2013

Conditions

Outcome Measures

Primary Outcomes (1)

  • endothelial reperfusion injury

    Change in endothelial function (measured with flow mediated dilation) after ischaemia reperfusion injury (induced by 20 minutes ischemia) with and without precedence of ischaemic preconditioning (by 3 cycles of 5-minutes of ischaemia).

    cross-sectional observation (single time point)

Study Arms (4)

young, sedentary

Other: IPC

young, active

Other: IPC

old, sedentary

Other: IPC

old, active

Other: IPC

Interventions

IPCOTHER

repeated cuff inflation (220 mmhg) around an upper limb for 5 minutes, followed by 5 minutes of reperfusion (repeated 4 times)

old, activeold, sedentaryyoung, activeyoung, sedentary

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Study population: Young sedentary volunteers (n=23, age 18-30), young active volunteers (n=23, age 18-30), older sedentary subjects (n=23, \>55 years) and older physically active subjects (n=23, \>55 years).

You may qualify if:

  • Healthy young volunteers : age 18-30
  • Healthy older volunteers: age \>55 years
  • Sedentary: \<1 h exercise per week
  • Trained: \>5 h exercise per week
  • All subjects: written informed consent

You may not qualify if:

  • Smoking
  • History of any cardiovascular disease
  • Hypertension (in supine position: systole \>140 mmHg, diastole \>90 mmHg)
  • Diabetes Mellitus (fasting glucose \>7.0 mmol/L or random glucose \>11.0 mmol/L)
  • Hyperlipidaemia (fasting total cholesterol \>6.5 mmol/L)
  • Chronic use of medication known to interfere with the cardiovascular system
  • Professional athletes
  • BMI \>30 kg/m2

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Physiology

Nijmegen, 6525 EX, Netherlands

Location

MeSH Terms

Conditions

Cardiovascular Diseases

Study Officials

  • Dick Thijssen, PhD

    Radboud University Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 23, 2012

First Posted

May 25, 2012

Study Start

April 1, 2011

Primary Completion

November 1, 2013

Study Completion

November 1, 2013

Last Updated

November 20, 2013

Record last verified: 2013-11

Locations